Mindfulness-Based Stress Reduction for Generalized Anxiety Disorder
Trial Summary
What is the purpose of this trial?
This trial compares mindfulness meditation and stress education in people with Generalized Anxiety Disorder (GAD). It aims to see how these treatments change brain areas that handle fear and stress. The study also looks at whether men and women respond differently to mindfulness meditation. Brain scans will help understand these changes and predict who might benefit most from mindfulness meditation. Mindfulness-based stress reduction has been shown to effectively reduce symptoms of anxiety and panic in patients with generalized anxiety disorder.
Will I have to stop taking my current medications?
You will need to stop taking benzodiazepines, antipsychotics, and stimulants for at least 4 weeks before starting the trial. However, if you are on antidepressants and have been stable on them for at least 4 weeks, you can continue taking them during the study.
What data supports the effectiveness of the treatment Mindfulness-Based Stress Reduction (MBSR) for Generalized Anxiety Disorder?
Research shows that Mindfulness-Based Stress Reduction (MBSR) can help improve mental health and reduce symptoms of stress, anxiety, and depression in both clinical and non-clinical groups. A specific study on generalized anxiety disorder found that MBSR was effective in reducing anxiety and stress reactivity.12345
Is Mindfulness-Based Stress Reduction (MBSR) safe for humans?
Mindfulness-Based Stress Reduction (MBSR) is generally considered safe for humans and has been used for various conditions like anxiety, depression, and chronic pain. It is a meditation therapy that does not involve medication, and studies suggest it can improve mental health without significant safety concerns.12456
How is the Mindfulness-Based Stress Reduction treatment different from other treatments for generalized anxiety disorder?
Mindfulness-Based Stress Reduction (MBSR) is unique because it uses mindfulness meditation to help reduce anxiety and stress without medication, focusing on being present in the moment. Unlike traditional therapies, it is a non-drug approach that can improve mental health and reduce symptoms of anxiety, stress, and depression in both clinical and non-clinical settings.12478
Research Team
Naomi Simon, MD
Principal Investigator
NYU Langone Health
Candace Raio, PhD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for adults aged 18-50 with Generalized Anxiety Disorder (GAD) who experience at least mild anxiety. Participants must be male or pre-menopausal females, not pregnant, using contraception if applicable, and vaccinated against COVID-19. They should not have certain psychiatric conditions or recent substance abuse issues and must agree to avoid alcohol during the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessments including fMRI scans and clinical evaluations
Treatment
Participants undergo 8 weeks of group intervention with either MBSR or stress education
Experimental Days
Two sets of experimental days including fMRI scans to assess neural changes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Mindfulness Based Stress Reduction MBSR Intervention (Behavioral Intervention)
- Stress Education Control Condition (SE) (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Dr. Alec C. Kimmelman
NYU Langone Health
Chief Executive Officer
MD and PhD from Mount Sinai School of Medicine
Dr. Nicole M. Adler
NYU Langone Health
Chief Medical Officer since 2023
MD